数字疗法在儿童弱视中的事实证据:对快速眼轴增长风险的洞察
DTx组快速眼轴增长(RAE)风险增加65%(HR 1.65,95%CI 1.40-1.96,P<0.001),各亚组一致,远视儿童尤为明显。作者认为DTx虽改善视力,但需平衡其对眼轴增长的影响,尤其远视和近视前期儿童。
要点
- DTx使弱视儿童RAE风险增加65%(HR 1.65,95%CI 1.40-1.96,P<0.001)。
- 各亚组交互作用P>0.05,风险增加在远视儿童中尤为明显。
- 作者认为DTx虽改善视力,但需平衡其对眼轴增长的影响。
核心结论
- 数字疗法与弱视儿童快速眼轴增长风险增加相关,提示治疗期间需仔细监测眼轴长度。
- 尽管DTx改善视力,但其对眼轴增长的潜在影响应予平衡,尤其远视和近视前期儿童。
研究设计与样本
- DTx组每日进行30分钟视觉训练,基线和随访时测量眼轴长度。
- 采用Cox比例风险模型评估RAE风险,调整年龄、性别、最佳矫正视力、睫状肌麻痹等效球镜度、弱视眼、弱视类型和基线眼轴长度。
主要发现
- 641名儿童(45.98%)发生RAE。
- DTx使用使RAE风险增加65%(HR 1.65;95%CI 1.40-1.96;P<0.001)。
- 所有亚组结果一致(交互作用P>0.05)。
- 风险增加在远视儿童中尤为明显,提示DTx可能影响该人群眼轴增长。
关键数值与推荐
- RAE定义为基于年龄和近视状态的年眼轴增长超过安全阈值。
- 主要结局为DTx相关RAE的风险比(HR),调整年龄、性别、最佳矫正视力、睫状肌麻痹等效球镜度、弱视眼、弱视类型和基线眼轴长度。
临床怎么用
- 作者认为数字疗法与弱视儿童RAE风险增加相关,提示治疗期间需仔细监测眼轴长度。
- 作者认为尽管DTx改善视力,但其对眼轴增长的潜在影响应予平衡,尤其远视和近视前期儿童。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the impact of daily digital therapeutics (DTx) on the risk of rapid axial elongation (RAE) in children with amblyopia using data from clinical settings. DESIGN: Retrospective cohort study. PARTICIPANTS: One thousand three hundred ninety-four children 3-to-12 years of age with amblyopia, 477 of whom received DTx. METHODS: Children in the DTx group underwent 30 minutes of daily vision therapy, with axial length (AL) measured at baseline and during follow-up. Cox proportional hazards models were used to assess the risk of RAE, defined as an annual axial elongation exceeding safety thresholds based on age and myopia status. MAIN OUTCOME MEASURES: The primary outcome was the hazard ratio (HR) for RAE associated with DTx, adjusted for age, sex, best-corrected visual acuity, cycloplegic spherical equivalent refraction, amblyopic eye, type of amblyopia, and baseline AL. RESULTS: Six hundred forty-one children (45.98%) experienced RAE. Use of DTx increased the risk of RAE by 65% (HR, 1.65; 95% confidence interval, 1.40-1.96; P < 0.001), with consistent findings across all subgroups (P > 0.05 for interaction). The increased risk was noted particularly in children with hyperopia, suggesting the potential for DTx to influence axial growth in this population. CONCLUSIONS: Digital therapeutics are associated with an increased risk of RAE in children with amblyopia, highlighting the need for careful monitoring of AL during therapy. Although DTx offers visual acuity improvements, its potential impact on ocular growth should be balanced, particularly in children with hyperopia and premyopia. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found after the references in the Footnotes and Disclosures at the end of this article.
引用
- Yao Y, He Y, Wen Y, et al. Factual Evidence on Digital Therapeutics in Pediatric Amblyopia: Insights into Rapid Axial Elongation Risk. Ophthalmology. 2025. PMID: 39814322. doi:10.1016/j.ophtha.2025.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。